🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Drug Acquiring Traction Online

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these accounts directly for source information, while also receiving promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and assertions of rapid UK delivery. Sellers promote the drug there before redirecting customers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in individuals administering substances of unknown origin.

Several professionals stated the popularity for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or prison.

Service Reaction and Content Removal

Based on the social media company, the platform has removed violative content and prohibited associated hashtags and search suggestions. The company said it was dedicated to keeping the service safe and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Investigations also found groups with up to nine thousand members marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of members, filled with photos of weight loss, positive testimonials and step-by-step guides for mixing or administering at home.

After minutes of entering one community, a seller posted contact information, where the majority of purchases take place. The seller sent an guidebook and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.

Product Information and Costs

Inside these communities, messages show dark colored packages with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When asked how much time a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for Telegram stated it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting materials they cannot confirm. Even if the science behind retatrutide is valid, these digital products may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for approved slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has previously encountered patients harmed by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject users to possibly significant health risks”.